| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 66.41B | 63.52B | 56.59B | 50.62B | 48.68B | 41.93B |
| Gross Profit | 11.98B | 14.50B | 7.17B | 5.68B | 12.03B | 13.27B |
| EBITDA | 11.50B | 6.72B | 735.00M | -648.00M | 7.88B | 7.81B |
| Net Income | 8.38B | 4.67B | -188.00M | -1.29B | 1.61B | 5.58B |
Balance Sheet | ||||||
| Total Assets | 120.40B | 111.62B | 103.36B | 97.99B | 99.44B | 125.99B |
| Cash, Cash Equivalents and Short-Term Investments | 931.00M | 5.24B | 5.87B | 4.91B | 4.77B | 7.12B |
| Total Debt | 8.09B | 8.09B | 7.94B | 7.96B | 7.98B | 7.83B |
| Total Liabilities | 92.91B | 90.25B | 85.73B | 80.63B | 74.31B | 95.77B |
| Stockholders Equity | 27.50B | 21.44B | 17.77B | 17.49B | 25.18B | 30.22B |
Cash Flow | ||||||
| Free Cash Flow | 11.35B | 8.72B | 3.96B | 4.70B | 4.77B | 5.18B |
| Operating Cash Flow | 11.57B | 8.93B | 4.23B | 5.12B | 5.12B | 5.49B |
| Investing Cash Flow | -6.98B | -8.25B | -3.00B | -1.73B | 510.00M | -3.44B |
| Financing Cash Flow | -1.85B | -697.00M | -1.24B | -3.42B | -5.24B | -2.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $111.39B | 11.82 | 14.06% | 1.31% | 6.68% | -1.78% | |
78 Outperform | $61.62B | 10.86 | 19.81% | 1.54% | 6.75% | 30.83% | |
77 Outperform | $51.32B | 6.31 | 34.63% | 1.94% | 7.07% | 100.42% | |
74 Outperform | $35.65B | 10.45 | 20.07% | 1.66% | 7.11% | 22.52% | |
74 Outperform | $122.91B | 11.49 | 34.23% | 2.26% | 18.35% | 32.36% | |
74 Outperform | $25.18B | 12.01 | 14.53% | 2.08% | -0.63% | -30.68% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
Allstate Corp’s recent earnings call paints a picture of robust financial health, marked by significant growth in revenue, profit, and investment income. While the company faces challenges in certain segments, such as increased claims in protection plans and regulatory hurdles in New York and New Jersey, its strategic initiatives and cost reduction efforts are driving growth. The focus on leveraging technology for future expansion is a key highlight of the call.
Allstate has announced its estimated catastrophe losses and policies in force for September 2025. This release provides insights into the company’s financial performance and operational impact, reflecting its ongoing commitment to transparency with stakeholders.
The most recent analyst rating on (ALL) stock is a Buy with a $223.00 price target. To see the full list of analyst forecasts on Allstate stock, see the ALL Stock Forecast page.
Allstate Corporation announced significant changes to its senior leadership team, effective October 1, 2025. Mario Rizzo will become the Chief Operating Officer, Jesse E. Merten will succeed him as President of Property-Liability, and John E. Dugenske will serve as interim Chief Financial Officer while maintaining his role as President of Investments and Corporate Strategy. These leadership changes are expected to impact the company’s operations and strategic direction, with adjustments in executive compensation reflecting their new roles.
The most recent analyst rating on (ALL) stock is a Hold with a $233.00 price target. To see the full list of analyst forecasts on Allstate stock, see the ALL Stock Forecast page.
In August 2025, Allstate released its monthly report detailing estimated catastrophe losses and policies in force, which is available on their investor website. This announcement provides stakeholders with insights into the company’s financial impact from recent events, potentially affecting its market positioning and operational strategies.
The most recent analyst rating on (ALL) stock is a Buy with a $221.00 price target. To see the full list of analyst forecasts on Allstate stock, see the ALL Stock Forecast page.
In July 2025, Allstate released its monthly report detailing estimated catastrophe losses and policies in force, which is available on their investor website. This announcement provides insights into the company’s financial health and operational status, potentially impacting its market position and stakeholder interests.
The most recent analyst rating on (ALL) stock is a Buy with a $235.00 price target. To see the full list of analyst forecasts on Allstate stock, see the ALL Stock Forecast page.